Takeda Pharmaceutical Company Limited Interest Received Classified As Investing Activities
Takeda Pharmaceutical Company Limited (TKPHF) reported Interest Received Classified As Investing Activities of JPY 17.66 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:InterestReceivedClassifiedAsInvestingActivities · last filed 2025-06-25
| Period end | Interest Received Classified As Investing Activities 12 month |
|---|---|
| 2025-03-31 | 17.66B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 11.16B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 5.05B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 2.92B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.10B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 11.49B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 6.30B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 2.41B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 2.00B JPY 20-F · filed 2019-06-27 |